- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07401407
Aderenza al Percorso RICA (ERAS) e Fattibilità della Dimissione Precoce Dopo Appendicectomia Urgente Non Complicata (APENERAS) (APENERAS)
APENERAS: Studio Osservazionale Multicentrico Prospettico sull'Adesione al Percorso RICA (ERAS), sugli Esiti di Sicurezza e sulla Fattibilità della Dimissione Precoce in Adulti Sottoposti ad Appendicectomia Urgente Non Complicata
This multicenter, prospective observational study (APENERAS) evaluates adherence to the RICA (ERAS Zaragoza 2022) perioperative care pathway in adults undergoing urgent laparoscopic appendectomy for uncomplicated acute appendicitis. The study aims to describe real-world adherence to the pathway across participating hospitals and to explore its association with patient safety and recovery outcomes.
Key outcomes include postoperative complications (including severity), length of hospital stay, and readmissions within 30 days. Patient-reported satisfaction is also assessed using a structured survey. In addition, the study evaluates the feasibility of early discharge/ambulatory management by intention-to-treat, using a standardized checklist of clinical, functional, and social discharge criteria assessed during the first 24 hours after surgery.
No changes to usual clinical care are introduced. Data are collected from routine perioperative management and follow-up.
Panoramica dello studio
Stato
Descrizione dettagliata
APENERAS is a prospective, multicenter observational study conducted in adult patients undergoing urgent laparoscopic appendectomy for uncomplicated acute appendicitis. The study assesses real-world adherence to the RICA (ERAS Zaragoza 2022) pathway, a structured set of perioperative recommendations intended to optimize recovery and standardize care in urgent surgery settings.
The primary objective is to quantify overall adherence and adherence by individual components of the pathway. Secondary objectives include evaluating the association between adherence and (1) postoperative safety outcomes (complications and severity classification), (2) efficiency outcomes (length of stay), (3) unplanned healthcare use (readmissions within 30 days), and (4) patient experience (satisfaction survey completed at discharge). In addition, feasibility of early discharge/ambulatory management is assessed by intention-to-treat using a standardized discharge-readiness checklist (clinical stability, pain control with oral analgesia, oral tolerance, mobilization, spontaneous urination, wound status, and social support), evaluated during the first postoperative day.
Candidate profiles for early discharge are also explored using established clinical prediction tools (e.g., Saint-Antoine Score), together with demographic and clinical covariates. Follow-up is performed up to 30 days after surgery to capture postoperative events and readmissions.
This study does not involve any experimental intervention, drug, or device, and does not require changes to standard clinical practice. It is based on systematic data collection from routine care processes and clinical records in each participating center.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Alicante
-
Elche, Alicante, Spagna, 03203
- Hospital General Universitario de Elche
-
-
Barcelona
-
Igualada, Barcelona, Spagna, 08700
- Hospital Universitari d'Igualada
-
Sabadell, Barcelona, Spagna, 08208
- Hospital Universitari Parc Taulí
-
-
Vizcaya
-
Galdakao, Vizcaya, Spagna, 48960
- Hospital Galdakao-Usansolo
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Adults aged 18-75 years undergoing urgent laparoscopic appendectomy for uncomplicated acute appendicitis in participating hospitals. The study evaluates adherence to the RICA (ERAS Zaragoza 2022) pathway in routine clinical practice, early discharge feasibility (8, 12, and 24 hours after surgery), and safety outcomes (complications, readmissions, reinterventions, and mortality) up to 30 days after surgery. No experimental intervention is introduced.
Descrizione
Inclusion Criteria:
- Age ≥ 18 and ≤ 75 years.
- Immunocompetent patients.
- ASA physical status I-III.
- Preoperative diagnosis of uncomplicated acute appendicitis (based on clinical assessment, laboratory tests, and imaging such as ultrasound and/or CT according to availability).
- Indication for urgent appendectomy for uncomplicated appendicitis.
- Laparoscopic approach.
- Expected operative time < 90 minutes.
- Cooperative patient able to understand and follow instructions.
- Voluntary participation and written informed consent.
- Adequate social/family support (availability of a responsible adult for transport home and support during the first postoperative days).
- Travel time from home to hospital < 1 hour and access to transportation.
- Acceptable home environment for recovery (telephone access and basic habitability/hygiene).
Exclusion Criteria:
- ASA physical status IV.
- Age < 18 years or > 75 years.
- BMI > 35 kg/m² with significant respiratory or cardiovascular complications.
- Ischemic heart disease class IV or acute myocardial infarction within the last 6 months.
- Congestive heart failure NYHA class III-IV.
- Sleep apnea or severe COPD, or need for home oxygen therapy.
- Poorly controlled diabetes mellitus.
- Severe psychiatric disorders, drug addiction, or severe alcoholism.
- History of major anesthesia-related complications or malignant hyperthermia.
- Epilepsy.
- Pregnancy.
- Use of anticoagulants, MAO inhibitors, systemic corticosteroids, or immunosuppressive drugs.
- Complicated appendicitis (gangrenous or perforated appendicitis, abscess, diffuse peritonitis).
- Severe sepsis.
- Primary open appendectomy or conversion to open surgery.
- Positive SARS-CoV-2 PCR or symptoms compatible with COVID-19.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: PROSPECTIVE
Coorti e interventi
Gruppo / Coorte |
|---|
|
Urgent Uncomplicated Appendectomy Cohort
Adults undergoing urgent laparoscopic appendectomy for uncomplicated acute appendicitis in participating hospitals. Perioperative management follows routine clinical practice. The adherence to the RICA (ERAS) pathway items is assessed, along with safety outcomes and early discharge feasibility. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Overall adherence to the RICA (ERAS Zaragoza 2022) pathway
Lasso di tempo: From day of surgery through postoperative day 1 or hospital discharge (whichever occurs first).
|
Overall adherence will be quantified as the proportion (%) of prespecified RICA (ERAS Zaragoza 2022) items fulfilled per participant and overall, using the study case report form. Adherence will be reported as a global percentage and by individual pathway components. |
From day of surgery through postoperative day 1 or hospital discharge (whichever occurs first).
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Early discharge feasibility at 8, 12 and 24 hours after surgery
Lasso di tempo: 8, 12 and 24 hours after surgery.
|
Feasibility of early discharge will be assessed by intention-to-treat using a standardized discharge-readiness checklist (clinical stability, respiratory stability, orientation, mobility, oral intake, urination, wound status, and social support/logistics). The proportion of patients meeting all criteria at each timepoint (8h, 12h, 24h) will be reported. |
8, 12 and 24 hours after surgery.
|
|
Postoperative complications and severity (Clavien-Dindo)
Lasso di tempo: Up to 30 days after surgery.
|
Postoperative complications will be recorded and graded according to the Clavien-Dindo classification. |
Up to 30 days after surgery.
|
|
Length of hospital stay
Lasso di tempo: From surgery to hospital discharge, assessed up to 30 days after surgery.
|
Length of stay will be measured as time from surgery to hospital discharge (reported in days and/or hours as available). |
From surgery to hospital discharge, assessed up to 30 days after surgery.
|
|
Readmission within 30 days
Lasso di tempo: Up to 30 days after surgery.
|
Unplanned readmissions for any cause will be recorded. |
Up to 30 days after surgery.
|
|
Patient satisfaction score
Lasso di tempo: Up to 30 days after surgery.
|
Patient satisfaction will be assessed using a structured survey delivered at hospital discharge and collected during postoperative follow-up. The overall satisfaction score (0-10 scale) and relevant domains will be analyzed. Higher scores indicate greater patient satisfaction. |
Up to 30 days after surgery.
|
|
Saint-Antoine Score for early discharge eligibility prediction within 24 hours after surgery
Lasso di tempo: Baseline (preoperative; assessed immediately before surgery).
|
The Saint-Antoine Score is a 5-point preoperative clinical score (range: 0 to 5) calculated at baseline (immediately before surgery) as the sum of five low-risk criteria (each criterion = 1 point; total score 0-5). Higher scores indicate a greater likelihood of eligibility for unplanned early discharge within 24 hours (better discharge readiness/lower-risk profile). Lower scores indicate a lower likelihood of early discharge eligibility. Predictive performance will be described (e.g., proportion eligible across score categories and discrimination metrics, as applicable). |
Baseline (preoperative; assessed immediately before surgery).
|
|
Reintervention within 30 days
Lasso di tempo: Up to 30 days after surgery.
|
Any unplanned reintervention after the index appendectomy, including surgical reoperation (e.g., re-laparoscopy/laparotomy) and other invasive procedures (e.g., percutaneous drainage), will be recorded. |
Up to 30 days after surgery.
|
|
All-cause mortality within 30 days
Lasso di tempo: Up to 30 days after surgery.
|
All-cause mortality will be recorded. |
Up to 30 days after surgery.
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Direttore dello studio: Bakarne Ugarte-Sierra, PhD, Grupo español de rehabilitación multimodal (GERM)
- Direttore dello studio: José Manuel Ramírez-Rodríguez, PhD, Grupo español de rehabilitación multimodal (GERM)
Pubblicazioni e link utili
Pubblicazioni generali
- Di Saverio S, Podda M, De Simone B, Ceresoli M, Augustin G, Gori A, Boermeester M, Sartelli M, Coccolini F, Tarasconi A, De' Angelis N, Weber DG, Tolonen M, Birindelli A, Biffl W, Moore EE, Kelly M, Soreide K, Kashuk J, Ten Broek R, Gomes CA, Sugrue M, Davies RJ, Damaskos D, Leppaniemi A, Kirkpatrick A, Peitzman AB, Fraga GP, Maier RV, Coimbra R, Chiarugi M, Sganga G, Pisanu A, De' Angelis GL, Tan E, Van Goor H, Pata F, Di Carlo I, Chiara O, Litvin A, Campanile FC, Sakakushev B, Tomadze G, Demetrashvili Z, Latifi R, Abu-Zidan F, Romeo O, Segovia-Lohse H, Baiocchi G, Costa D, Rizoli S, Balogh ZJ, Bendinelli C, Scalea T, Ivatury R, Velmahos G, Andersson R, Kluger Y, Ansaloni L, Catena F. Diagnosis and treatment of acute appendicitis: 2020 update of the WSES Jerusalem guidelines. World J Emerg Surg. 2020 Apr 15;15(1):27. doi: 10.1186/s13017-020-00306-3.
- Scott MJ, Aggarwal G, Aitken RJ, Anderson ID, Balfour A, Foss NB, Cooper Z, Dhesi JK, French WB, Grant MC, Hammarqvist F, Hare SP, Havens JM, Holena DN, Hubner M, Johnston C, Kim JS, Lees NP, Ljungqvist O, Lobo DN, Mohseni S, Ordonez CA, Quiney N, Sharoky C, Urman RD, Wick E, Wu CL, Young-Fadok T, Peden CJ. Consensus Guidelines for Perioperative Care for Emergency Laparotomy Enhanced Recovery After Surgery (ERAS(R)) Society Recommendations Part 2-Emergency Laparotomy: Intra- and Postoperative Care. World J Surg. 2023 Aug;47(8):1850-1880. doi: 10.1007/s00268-023-07020-6. Epub 2023 Jun 5.
- Raimbert P, Voron T, Laroche S, O'Connell L, Debove C, Challine A, Parc Y, Lefevre JH. Ambulatory appendectomy for acute appendicitis: Can we treat all the patients? A prospective study of 451 consecutive ambulatory appendectomies out of nearly 2,000 procedures. Surgery. 2023 May;173(5):1129-1136. doi: 10.1016/j.surg.2023.01.003. Epub 2023 Feb 10.
- Gignoux B, Blanchet MC, Lanz T, Vulliez A, Saffarini M, Bothorel H, Robert M, Frering V. Should ambulatory appendectomy become the standard treatment for acute appendicitis? World J Emerg Surg. 2018 Jun 28;13:28. doi: 10.1186/s13017-018-0191-4. eCollection 2018.
- Ruiz-Tovar J, Llavero C, Perez-Lopez M, Garcia-Marin A. Implementation of an Enhanced Recovery After Surgery (ERAS) protocol for acute complicated and uncomplicated appendicitis. Tech Coloproctol. 2021 Sep;25(9):1073-1078. doi: 10.1007/s10151-021-02484-x. Epub 2021 Jun 26.
- Trejo-Avila ME, Romero-Loera S, Cardenas-Lailson E, Blas-Franco M, Delano-Alonso R, Valenzuela-Salazar C, Moreno-Portillo M. Enhanced recovery after surgery protocol allows ambulatory laparoscopic appendectomy in uncomplicated acute appendicitis: a prospective, randomized trial. Surg Endosc. 2019 Feb;33(2):429-436. doi: 10.1007/s00464-018-6315-9. Epub 2018 Jul 9.
- Postigo-Morales S, Ugarte-Sierra B, San-Juan-Gonzalez M, Ramirez-Rodriguez JM. [Implementation of the ERAS pathway in emergency surgery: adherence, barriers and facilitators]. J Healthc Qual Res. 2026 Jan-Feb;41(1):101170. doi: 10.1016/j.jhqr.2025.101170. Epub 2025 Oct 31. Spanish.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- PI2022120
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
De-identified individual participant data (IPD) underlying the results reported in publications will be shared. The shared dataset will contain coded study IDs and will exclude direct identifiers (e.g., name, medical record number, address). Variables will be minimized/modified as needed to reduce re-identification risk in accordance with GDPR and institutional policies.
Periodo di condivisione IPD
Available beginning 12 months after publication of the primary results and for 5 years thereafter.
Criteri di accesso alla condivisione IPD
Access will be granted to researchers with a clear research question and an appropriate analysis plan, subject to review and approval by the study team and compliance with GDPR and applicable institutional policies. Data will be provided in de-identified form after completion of a data sharing agreement. Requests should be submitted by email to: estudioapeneras@gmail.com
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .